Across Canada, healthcare providers are closely revising their approaches to BZD prescribing following the publication of new guidelines. These recommendations aim to lower the risks associated with long-term use and dependence, stressing the critical need of detailed patient reviews and considering non-pharmacological treatment possibilities. The